20-HETE requires increased vascular tone to constrict rabbit afferent arterioles

Hypertension

Volumn 27, Issue 3 II, 1996, Pages 781-785

  Arima, Shuji ^a   Omata, Ken ^a   Ito, Sadayoshi ^a   Tsunoda, Kazuo ^a   Abe, Keishi ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

arachidonic acid; cytochrome P 450; endothelium; microcirculation; prostaglandin endoperoxide synthase

Indexed keywords

ARACHIDONIC ACID; CYTOCHROME P450; HYDROXYICOSATETRAENOIC ACID; PROSTAGLANDIN ENDOPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; ENDOTHELIUM; HYPERTENSION; KIDNEY BLOOD FLOW; MALE; MICROCIRCULATION; NONHUMAN; PRIORITY JOURNAL; RABBIT;

EID: 0029866052     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.27.3.781     Document Type: Conference Paper

References (29)

1. Sacerdoti D, Abraham NG, McGiff JC, Schwartzman ML. Renal cytochrome P-450-dependent metabolism of arachidonic acid in spontaneously hypertensive rats. Biochem Pharmacol. 1988;37: 521-527.
2. Sacerdoti D, Escalante B, Abraham NG, McGiff JC, Schwartzman ML. Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats. Science. 1989;243:388-390.
3. Omata K, Abraham NG, Escalante B, Schwartzman ML. Age-related changes in renal cytochrome P-450 arachidonic acid metabolism in spontaneously hypertensive rats. Am J Physiol. 1992;262: F8-F16.
4. Levere RD, Martasek P, Escalante B, Schwartzman ML, Abraham NG. Effect of heme arginate administration on blood pressure in spontaneously hypertensive rats. J Clin Invest. 1990;86:213-219.
5. Escalante B, Sessa WC, Falck JR, Yadagiri P, Schwartzman ML. Vasoactivity of 20-hydroxyeicosatetraenoic acid is dependent on metabolism by cyclooxygenase. J Pharmacol Exp Ther. 1989;248: 229-232.
6. Ma YH, Gebremedhin D, Schwartzman ML, Falck JR, Clark JE, Masters BS, Harder DR, Roman RJ. 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine arcuate arteries. Circ Res. 1993;72:126-136.
7. Harder DR, Gebremedhin D, Narayanan J, Jefcoat C, Falck JR, Campbell WB, Roman RJ. Formation and action of a P-450 4A metabolite of arachidonic acid in cat cerebral microvessels. Am J Physiol. 1994;266:H2098-H2107.
8. Morrison AR, Pascoe N. Metabolism of arachidonate through NADPH-dependent oxygenase of renal cortex. Proc Natl Acad Sci USA. 1981;78:7375-7378.
9. Oliw EH, Lawson JA, Brash AR, Dates JA. Arachidonic acid metabolism in rabbit renal cortex. J Biol Chem. 1981;256:9924-9931.
10. Schwartzman ML, Martasek P, Rios AR, Levere RD, Solangi K, Goodman AI, Abraham NG. Cytochrome P-450-dependent arachidonic acid metabolism in human kidney. Kidney Int. 1990;37:94-99.
11. Zou AP, Imig JD, Kaldunski M, Ortiz de Montellano PR, Sui Z, Roman RJ. Inhibition of renal vascular 20-HETE production impairs autoregulation of renal blood flow. Am J Physiol. 1994;266: F275-F282.
12. Zou AP, Imig JD, Ortiz de Montellano PR, Sui Z, Falck JR, Roma RJ. Effect of P-450 ω-hydroxylase metabolites of arachidonic acid on tubuloglomerular feedback. Am J Physiol. 1994;266:F934-F941.
13. Kauser K, Clark JE, Masters BS, Ortiz de Montellano PR, Ma YH, Harder DR, Roman RJ. Inhibitors of cytochrome P-450 attenuate the myogenic response of dog renal arcuate arteries. Circ Res. 1991; 68:1154-1163.
14. Imig JD, Falck JR, Gebremedhin D, Harder DR, Roman RJ. Elevated renovascular tone in young spontaneously hypertensive rats: role of cytochrome P-450. Hypertension. 1993;22:357-364.
15. Ito S, Arima S, Ren YL, Juncos LA, Carretero OA. Endothelium-derived relaxing factor/nitric oxide modulates angiotensin II action in the isolated microperfused rabbit afferent but not efferent arteriole. J Clin Invest. 1993;91:2012-2019.
16. Arima S, Ren YL, Juncos LA, Carretero OA, Ito S. Glomerular prostaglandins modulate vascular reactivity of the downstream efferent arterioles. Kidney Int. 1994;45:650-658.
17. Arima S, Ito S, Omata K, Takeuchi K, Abe K. High glucose augments angiotensin II action by inhibiting NO synthesis in in vitro microperfused rabbit afferent arterioles. Kidney Int. 1995;48: 683-689.
18. G-nitro arginine (L-NOARG), a novel L-arginine-reversible inhibitor of endothelium dependent vasodilatation in vitro. Br J Pharmacol. 1990;99:408-412.
19. Ito S, Johnson CS, Carretero OA. Modulation of angiotensin II-induced vasoconstriction by endothelium-derived relaxing factor in the isolated microperfused rabbit afferent arteriole. J Clin Invest. 1991;87:1656-1663.
20. Juncos LA, Ito S, Carretero OA, Garvin JL. Removal of endothelium dependent relaxation by antibody and complement in afferent arterioles. Hypertension. 1994;23(suppl I):I-54-I-59.
21. Itoh S, Carretero OA. Role of macula densa in renin release. Hypertension. 1985;7(suppl I):I-49-I-54.
22. Trippodo NC, Frohlich ED. Similarities of genetic (spontaneous) hypertension: man and rat. Circ Res. 1981;48:309-319.
23. Beierwaltes WH, Arendshorst WJ, Klemmer PJ. Electrolyte and water balance in young spontaneously hypertensive rats. Hypertension. 1982;4:908-915.
24. Schwartzman ML, Falck JR, Yadagiri P, Escalante B. Metabolism of 20-hydroxyeicosatetraenoic acid by cyclooxygenase: formation and identification of novel endothelium-dependent vasoconstrictor metabolites. J Biol Chem. 1989;264:11658-11662.
25. Imig JD, Falck JR, Roman RJ. 20-Hydroxyeicosatetraenoic acid (20-HETE) is a potent endogenous constrictor of renal arterioles. FASEB J. 1993;7:A888. Abstract.
26. Steinhausen M, Ballantyne D, Fretschner M, Hoffend J, Parekh N. Different responses of cortical and juxtamedullary arterioles to norepinephrine and angiotensin II. Kidney Int. 1990;38(suppl 30): S55-S59.
27. McGiff JC. Cytochrome P-450 metabolism of arachidonic acid. Annu Rev Pharmacol Toxicol. 1991;31:339-369.
28. Imig JD, Navar GL. Differential involvement of enzymatic pathways in the afferent arteriolar response to arachidonic acid. J Am Soc Nephrol. 1994;5:605. Abstract.
29. Escalante B, Erlij D, Falck JR, McGiff JC. Effect of cytochrome P450 arachidonate metabolites on ion transport in rabbit kidney loop of Henle. Science. 1991;251:799-802.